J Kopecky, JE Pérez, H Eriksson, E Visse, P Siesjö… - Scientific Reports, 2022 - nature.com
Glioblastoma has remained the deadliest primary brain tumor while its current therapy offers
only modest survival prolongation. Immunotherapy has failed to record notable benefits in …